Screener
Aktis Oncology, Inc. AKTS Q4 2025 Annual earnings
Reported February 25, 2026
Revenue$4.6M
EPS-$60.17
Next report
Date not yet announcedVersus estimates
FAQ
- When did Aktis Oncology, Inc. report Q4 2025 earnings?
- Aktis Oncology, Inc. (AKTS) reported Q4 2025 earnings on February 25, 2026.
- What were Aktis Oncology, Inc.'s Q4 2025 revenue and EPS?
- Aktis Oncology, Inc. reported revenue of $4.6M and eps of $-60.17 for Q4 2025.
- How did Aktis Oncology, Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 172.2% from $1.7M a year earlier and eps declined 4637.8% from $-1.27.
- Where can I find Aktis Oncology, Inc.'s Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001193125-26-131748) directly on SEC EDGAR. The filing index links above go to sec.gov.
